What's breaking now, across thousands of outlets.
(RTTNews) - Merck & Co., Inc. (MRK) announced positive results from the Phase 3 KEYNOTE-C93 trial, evaluating KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, as monotherapy for the treatment of patients with mismatch repair deficient (dMMR) advanced or recurrent endometrial
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
The Ghana Health Service (GHS) says it has activated its preparedness arrangements for Ebola and conducted simulation exercises as part of efforts to strengthen the country's ability to respond to a…
Prof John Amuasi, Leader of Global Health at the KCCR, has rejected suggestions that Ghana has let its disease screening systems slip since the COVID-19 pandemic.
Two new studies, including the first whole-brain lipid atlas in mice, uncover unforeseen complexity and influence during pregnancy and aging.
The government has ordered a review of the existing drug pricing formula to ensure medicines remain fairly priced, warning that … Read More The post Govt to Review Drug Pricing Formula for Fairer…
[263Chat] Zimbabwe has launched a US$14.33 million pandemic preparedness programme aimed at strengthening disease surveillance, laboratory testing and emergency response systems as the country steps…
Perimenopause has become a hot topic, with celebrities sharing their experiences and doctors offering tips and advice online.
